Idarucizumab dabigatran antidote: Clinical trial data

A clinical trial in 35 healthy volunteers treated with the anticoagulant Pradaxa dabigatran etexilate for 4 days showed

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE